Moody Lynn & Lieberson, LLC Abbott Laboratories Transaction History

Moody Lynn & Lieberson, LLC

$1.47 Billion
Q2 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 238,106 shares of ABT stock, worth $24.9 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares

238,106

Previous 240,543 1.01%

Holding current value

$24.9 Million

Previous $27.3 Million 9.51%

% of portfolio

1.68%

Previous 1.9%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $245,479 - $274,016	-2,437 Reduced 1.01%	238,106 $24.7 Million
Q1 2024 Apr 23, 2024	BUY	$109.52 - $120.96 $2.7 Million - $2.98 Million	24,673 Added 11.43%	240,543 $27.3 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $421,908 - $516,451	4,678 Added 2.22%	215,870 $23.8 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $164,407 - $197,261	1,721 Added 0.82%	211,192 $20.5 Million
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $408,159 - $454,774	4,050 Added 1.97%	209,471 $22.8 Million

Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $906,125 - $1.07 Million	-9,355 Reduced 4.36%	205,421 $20.8 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $216,071 - $253,484	-2,273 Reduced 1.05%	214,776 $23.6 Million
Q3 2022 Oct 26, 2022	SELL	$96.76 - $112.03 $1.01 Million - $1.17 Million	-10,464 Reduced 4.6%	217,049 $21 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $68,182 - $82,411	-668 Reduced 0.29%	227,513 $24.7 Million
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $3.92 Million - $4.78 Million	-34,379 Reduced 13.09%	228,181 $27 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $4.76 Million - $5.82 Million	41,164 Added 18.59%	262,560 $37 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $429,892 - $475,586	-3,685 Reduced 1.64%	221,396 $26.2 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $2.99 Million - $3.52 Million	-28,237 Reduced 11.15%	225,081 $26.1 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $171,858 - $202,475	-1,579 Reduced 0.62%	253,318 $30.4 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $31,185 - $33,982	-297 Reduced 0.12%	254,897 $27.9 Million
Q3 2020 Oct 28, 2020	BUY	$91.64 - $111.29 $174,116 - $211,451	1,900 Added 0.75%	255,194 $27.8 Million
Q2 2020 Jul 24, 2020	SELL	$76.57 - $98.0 $323,508 - $414,050	-4,225 Reduced 1.64%	253,294 $23.2 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $3.89 Million - $5.69 Million	-61,896 Reduced 19.38%	257,519 $20.3 Million
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $76,625 - $85,302	976 Added 0.31%	319,415 $27.7 Million
Q3 2019 Oct 28, 2019	BUY	$81.84 - $88.74 $5.08 Million - $5.51 Million	62,069 Added 24.21%	318,439 $26.6 Million
Q2 2019 Jul 23, 2019	SELL	$72.88 - $85.0 $285,616 - $333,115	-3,919 Reduced 1.51%	256,370 $21.6 Million
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $3.84 Million - $4.64 Million	-57,994 Reduced 18.22%	260,289 $20.8 Million
Q4 2018 Jan 29, 2019	BUY	$65.56 - $74.27 $2.5 Million - $2.83 Million	38,107 Added 13.6%	318,283 $23 Million
Q3 2018 Oct 29, 2018	BUY	$60.81 - $73.36 $1.1 Million - $1.33 Million	18,162 Added 6.93%	280,176 $20.6 Million
Q2 2018 Jul 24, 2018	BUY	$57.57 - $63.54 $883,238 - $974,830	15,342 Added 6.22%	262,014 $16 Million
Q1 2018 Apr 27, 2018	SELL	$56.27 - $63.62 $2.16 Million - $2.45 Million	-38,441 Reduced 13.48%	246,672 $14.8 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $2.22 Million - $2.38 Million	-41,355 Reduced 12.67%	285,113 $17.8 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $15.7 Million - $17.5 Million	326,468	326,468 $17.4 Million

Others Institutions Holding ABT

# of Institutions

3,111

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $183B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Abbott Laboratories Transaction History